Novalis LifeSciences — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Telesis Biotelesisbio.cominJun 2023
Telesis Bio develops automated platforms for RNA and DNA synthesis to accelerate therapeutic discovery workflows in drug development, cell and gene therapy, and vaccine development.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
Franklin R. Witney(Chair of the Board of Directors)Eric Esser(Executive Officer)William F. Snider(Director)Andrea L. Jackson(Director)Christine A. Tsingos(Director)Robert H. Cutler(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.